Company intelligence / Profile preview

Aerogen Pharma

Galway, County Galway, Irelandaerogenpharma.com ↗

Ownership: Private
Development stage: Other

Overview

Aerogen Pharma is developing proprietary inhaled medications using a patented nebulizer platform. Its lead program, AeroFact™, delivers surfactant non-invasively to preterm infants with respiratory distress syndrome. The company aims to improve safety and efficacy by targeting drugs directly to the lungs, with ongoing clinical trials but no published pivotal results yet.

Therapeutic areas: Pulmonology
Modalities: Inhaled drugs/biologics (liquid aerosolized formulations)
Industry: Biotech

Drug pipeline

1 asset

AeroFact

Clinical-stage

Indications: Respiratory distress syndrome

Partnerships

Not specifically listed for Aerogen Pharma; parent group has broad pharma/device partnerships.

Beyond the preview

Go deeper on Aerogen Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aerogen Pharma.

Explore the full profile